Hakan Erdem1, Seniha Senbayrak2, Kaan Meriç3, Ayşe Batirel4, Mustafa Kasım Karahocagil5, Rodrigo Hasbun6, Gonul Sengoz7, Hasan Karsen8, Selçuk Kaya9, Ayşe Seza Inal10, Abdullah Umut Pekok11, Mustafa Kemal Celen12, Secil Deniz2, Mehmet Ulug13, Tuna Demirdal14, Mustafa Namiduru15, Recep Tekin12, Tumer Guven16, Emine Parlak17, Sibel Bolukcu18, Meltem Avci19, Oguz Reşat Sipahi18, Derya Ozturk-Engin2, Kadriye Yaşar20, Filiz Pehlivanoglu7, Emel Yilmaz21, Selma Ates-Guler22, Esmeray Mutlu-Yilmaz23, Selma Tosun19, Fatma Sirmatel24, Elif Sahin-Horasan25, Ayhan Akbulut26, Nefise Oztoprak27, Yasemin Cag28, Ayten Kadanali29, Huseyin Turgut30, Ali Irfan Baran5, Hanefi Cem Gul31, Mahmut Sunnetcioglu5, Asli Haykir-Solay32, Affan Denk26, Asuman Inan2, Celal Ayaz12, Asim Ulcay31, Sukran Kose33, Canan Agalar34, Nazif Elaldi35. 1. Department of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Ankara, Turkey. hakanerdem1969@yahoo.com. 2. Department of Infectious Diseases and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey. 3. Department of Radiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey. 4. Department of Infectious Diseases and Clinical Microbiology, Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey. 5. Department of Infectious Diseases and Clinical Microbiology, Yuzuncuyil University School of Medicine, Van, Turkey. 6. Department of Infectious Diseases, Medical School, The University of Texas Health Science Center at Houston, Houston, USA. 7. Department of Infectious Diseases and Clinical Microbiology, Haseki Training and Research Hospital, Istanbul, Turkey. 8. Department of Infectious Diseases and Clinical Microbiology, Harran University, School of Medicine, Sanliurfa, Turkey. 9. Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey. 10. Department of Infectious Diseases and Clinical Microbiology, Cukurova University School of Medicine, Adana, Turkey. 11. Department of Infectious Diseases and Clinical Microbiology, Private Erzurum Sifa Hospital, Erzurum, Turkey. 12. Department of Infectious Diseases and Clinical Microbiology, Dicle University School of Medicine, Diyarbakir, Turkey. 13. Department of Infectious Diseases and Clinical Microbiology, Private Umit Hospital, Eskisehir, Turkey. 14. Department of Infectious Diseases and Clinical Microbiology, Katip Celebi University School of Medicine, Izmir, Turkey. 15. Department of Infectious Diseases and Clinical Microbiology, Gaziantep University School of Medicine, Gaziantep, Turkey. 16. Department of Infectious Diseases and Clinical Microbiology, Ankara Atatürk Training & Research Hospital, Ankara, Turkey. 17. Department of Infectious Diseases and Clinical Microbiology, Ataturk University School of Medicine, Erzurum, Turkey. 18. Department of Infectious Diseases and Clinical Microbiology, Bezmi Alem Vakif University School of Medicine, Istanbul, Turkey. 19. Department of Infectious Diseases and Clinical Microbiology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey. 20. Department of Infectious Diseases and Clinical Microbiology, Bakırkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey. 21. Department of Infectious Diseases and Clinical Microbiology, Uludag University School of Medicine, Bursa, Turkey. 22. Department of Infectious Diseases and Clinical Microbiology, Sutcu Imam University School of Medicine, Kahramanmaras, Turkey. 23. Department of Infectious Diseases and Clinical Microbiology, Samsun Training and Research Hospital, Samsun, Turkey. 24. Department of Infectious Diseases and Clinical Microbiology, Izzet Baysal University School of Medicine, Bolu, Turkey. 25. Department of Infectious Diseases and Clinical Microbiology, Mersin University School of Medicine, Mersin, Turkey. 26. Department of Infectious Diseases and Clinical Microbiology, Firat University School of Medicine, Elazig, Turkey. 27. Department of Infectious Diseases and Clinical Microbiology, Antalya Training and Research Hospital, Antalya, Turkey. 28. Department of Infectious Diseases and Clinical Microbiology, Medeniyet University, Goztepe Training ad Research Hospital, Istanbul, Turkey. 29. Department of Infectious Diseases and Clinical Microbiology, Umraniye Training and Research Hospital, Istanbul, Turkey. 30. Department of Infectious Diseases and Clinical Microbiology, Pamukkale University School of Medicine, Denizli, Turkey. 31. Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital, Istanbul, Turkey. 32. Department of Infectious Diseases and Clinical Microbiology, Igdir State Hospital, Igdir, Turkey. 33. Department of Infectious Diseases and Clinical Microbiology, Tepecik Training and Research Hospital, Izmir, Turkey. 34. Department of Infectious Diseases and Clinical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey. 35. Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University School of Medicine, Sivas, Turkey.
Abstract
OBJECTIVE: Neuroimaging abnormalities in central nervous system (CNS) brucellosis are not well documented. The purpose of this study was to evaluate the prevalence of imaging abnormalities in neurobrucellosis and to identify factors associated with leptomeningeal and basal enhancement, which frequently results in unfavorable outcomes. METHODS: Istanbul-3 study evaluated 263 adult patients with CNS brucellosis from 26 referral centers and reviewed their 242 magnetic resonance imaging (MRI) and 226 computerized tomography (CT) scans of the brain. RESULTS: A normal CT or MRI scan was seen in 143 of 263 patients (54.3 %). Abnormal imaging findings were grouped into the following four categories: (a) inflammatory findings: leptomeningeal involvements (44), basal meningeal enhancements (30), cranial nerve involvements (14), spinal nerve roots enhancement (8), brain abscesses (7), granulomas (6), and arachnoiditis (4). (b) White-matter involvement: white-matter involvement (32) with or without demyelinating lesions (7). (c) Vascular involvement: vascular involvement (42) mostly with chronic cerebral ischemic changes (37). (d) Hydrocephalus/cerebral edema: hydrocephalus (20) and brain edema (40). On multivariate logistic regression analysis duration of symptoms since the onset (OR 1.007; 95 % CI 1-28, p = 0.01), polyneuropathy and radiculopathy (OR 5.4; 95 % CI 1.002-1.013, p = 0.044), cerebrospinal fluid (CSF)/serum glucose rate (OR 0.001; 95 % CI 000-0.067, p = 0.001), and CSF protein (OR 2.5; 95 % CI 2.3-2.7, p = 0.0001) were associated with diffuse inflammation. CONCLUSIONS: In this study, 45 % of neurobrucellosis patients had abnormal neuroimaging findings. The duration of symptoms, polyneuropathy and radiculopathy, high CSF protein level, and low CSF/serum glucose rate were associated with inflammatory findings on imaging analyses.
OBJECTIVE:Neuroimaging abnormalities in central nervous system (CNS) brucellosis are not well documented. The purpose of this study was to evaluate the prevalence of imaging abnormalities in neurobrucellosis and to identify factors associated with leptomeningeal and basal enhancement, which frequently results in unfavorable outcomes. METHODS: Istanbul-3 study evaluated 263 adult patients with CNS brucellosis from 26 referral centers and reviewed their 242 magnetic resonance imaging (MRI) and 226 computerized tomography (CT) scans of the brain. RESULTS: A normal CT or MRI scan was seen in 143 of 263 patients (54.3 %). Abnormal imaging findings were grouped into the following four categories: (a) inflammatory findings: leptomeningeal involvements (44), basal meningeal enhancements (30), cranial nerve involvements (14), spinal nerve roots enhancement (8), brain abscesses (7), granulomas (6), and arachnoiditis (4). (b) White-matter involvement: white-matter involvement (32) with or without demyelinating lesions (7). (c) Vascular involvement: vascular involvement (42) mostly with chronic cerebral ischemic changes (37). (d) Hydrocephalus/cerebral edema: hydrocephalus (20) and brain edema (40). On multivariate logistic regression analysis duration of symptoms since the onset (OR 1.007; 95 % CI 1-28, p = 0.01), polyneuropathy and radiculopathy (OR 5.4; 95 % CI 1.002-1.013, p = 0.044), cerebrospinal fluid (CSF)/serum glucose rate (OR 0.001; 95 % CI 000-0.067, p = 0.001), and CSF protein (OR 2.5; 95 % CI 2.3-2.7, p = 0.0001) were associated with diffuse inflammation. CONCLUSIONS: In this study, 45 % of neurobrucellosis patients had abnormal neuroimaging findings. The duration of symptoms, polyneuropathy and radiculopathy, high CSF protein level, and low CSF/serum glucose rate were associated with inflammatory findings on imaging analyses.
Entities:
Keywords:
Computerized tomography; Diagnosis; Inflammation; Magnetic resonance imaging; Neurobrucellosis
Authors: J D Colmenero; M I Queipo-Ortuño; J M Reguera; G Baeza; J A Salazar; P Morata Journal: J Neurol Neurosurg Psychiatry Date: 2005-07 Impact factor: 10.154
Authors: Hanefi Cem Gul; Hakan Erdem; Levent Gorenek; Mehmet Fatih Ozdag; Yasin Kalpakci; Ismail Yasar Avci; Bulent Ahmet Besirbellioglu; Can Polat Eyigun Journal: Intern Med Date: 2008-06-02 Impact factor: 1.271
Authors: Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis Journal: PLoS One Date: 2022-09-30 Impact factor: 3.752